Objective
We will develop innovative therapeutic products and methods for the treatment of degenerative joint cartilage damage and bone loss in ageing people, using the novel technology of tissue engineering. This involves novel co-culture of antilogous chondrocytes, stem cells or bone cells, and novel biodegradable scaffolds to construct new cartilage and bone. New microvascularised tissue transfer methods will also be used. The quality and characteristics of the developed cartilage and bone, and the healing process, will be evaluated using biochemistry, photochemistry, histology, radiology, etc. The clinical pilot study includes particular resurfacing in osteoarthritis, and bone regeneration in the treatment of large cranial bone defects and open tibia fractures, for the benefit of ageing people in Europe. It is a transactional, multidisciplinary project that will increase cornpetitiveness and employment in Europe.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
- natural scienceschemical sciencesphysical chemistryphotochemistry
- medical and health sciencesmedical biotechnologytissue engineering
- medical and health sciencesclinical medicineradiology
- medical and health sciencesmedical biotechnologycells technologiesstem cells
- natural sciencesbiological scienceshistology
You need to log in or register to use this function
Call for proposal
Data not availableFunding Scheme
CSC - Cost-sharing contractsCoordinator
90221 OULU
Finland